LakeShore Biopharma Cost Of Revenue Over Time
| LSBPW Stock | 0.04 0 3.90% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out LakeShore Biopharma Performance and LakeShore Biopharma Correlation. LakeShore |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LakeShore Biopharma Co, is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cost Of Revenue Analysis
Compare LakeShore Biopharma Co, and related stocks such as Viemed Healthcare, Alvotech, and Tandem Diabetes Care Cost Of Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VMD | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 12.5 M | 12.3 M | 16.7 M | 24.2 M | 51.2 M | 43.7 M | 54.2 M | 70.2 M | 35.7 M |
| ALVO | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 64.1 M | 160.9 M | 168.9 M |
| TNDM | 3.8 M | 3.8 M | 3.8 M | 22.8 M | 34.5 M | 46.3 M | 60.7 M | 63.5 M | 94 M | 168.1 M | 238.3 M | 326.6 M | 388.2 M | 380 M | 399 M |
| HCM | 14.6 M | 74.2 M | 99.4 M | 22.2 M | 72 M | 110.8 M | 156.3 M | 175.8 M | 143.9 M | 160.2 M | 188.5 M | 258.2 M | 311.1 M | 384.4 M | 403.7 M |
| WEYS | 71.6 M | 164.4 M | 178.6 M | 183 M | 197.4 M | 199 M | 184.9 M | 173.1 M | 178.3 M | 180 M | 116.8 M | 160.2 M | 207.3 M | 175.2 M | 141.3 M |
| EML | 59.3 M | 115.5 M | 124.2 M | 112.3 M | 108.3 M | 112.2 M | 103.3 M | 154.2 M | 175.6 M | 189.9 M | 186.7 M | 189.8 M | 220.6 M | 208.5 M | 218.9 M |
| AVDL | 400 K | 6.3 M | 5.9 M | 4.3 M | 3.4 M | 10.9 M | 13.2 M | 16.3 M | 17.5 M | 12.1 M | 5.7 M | 815 K | 1.5 M | 846 K | 803.7 K |
| AQST | 1.3 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 19.8 M | 21 M | 20.4 M | 13 M | 15 M | 19.4 M | 20.8 M | 16.3 M |
LakeShore Biopharma Co, and related stocks such as Viemed Healthcare, Alvotech, and Tandem Diabetes Care Cost Of Revenue description
Cost of Revenue is found on LakeShore Biopharma Co, income statement and represents the costs associated with goods and services LakeShore Biopharma provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.My Equities
My Current Equities and Potential Positions
| LakeShore Biopharma Co, | LSBPW |
Specialization | Healthcare, Biotechnology |
| Location | China |
| Exchange | NASDAQ Exchange |
null 0.04
Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.